000 -LEADER |
fixed length control field |
00983cam a2200241 i 4500 |
001 - CONTROL NUMBER |
control field |
21986754 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20220718092929.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
210408s2023 maua bf 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2021016693 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781284223668 |
040 ## - Cataloging Source |
Transcribing Agency |
TUM |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RC606.63 |
Item number |
.H58 2023 |
245 00 - TITLE STATEMENT |
Title |
HIV essentials / |
Statement of responsibility, etc. |
Paul E. Sax, MD, Clinical Director, Division of Infectious Disease, Brigham and Women's Hospital, Professor of Medicine, Harvard Medical School, Boston, MA, Melanie Berry, PharmD, BCACP, Ambulatory Clinical Pharmacy Specialist-HIV, Beth Israel Deaconess Medical Center, Boston, MA. |
250 ## - EDITION STATEMENT |
Edition statement |
Ninth edition. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xii, 343 pages : |
Other physical details |
illustrations ; |
Dimensions |
17 x 12 cm |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references and index. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
HIV Infections |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
HIV Infections |
General subdivision |
drug therapy |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Anti-HIV Agents |
General subdivision |
therapeutic use |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Antiretroviral Therapy, Highly Active |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Sax, Paul E., |
Relator term |
editor. |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
|